GPX4 and nonpapillary renal cell carcinoma: (235) tested the sensitivity of 117 cancer cell lines to Erastin-induced ferroptosis and found that diffuse large B-cell lymphoma and clear cell renal cell carcinoma (ccRCC) were particularly sensitive to GPX4-regulated ferroptosis.